Page 33 - Read Online

Walker. Neuroimmunol Neuroinflammation 2020;7:194-214 I http://dx.doi.org/10.20517/2347-8659.2020.09 Page 211

13. Rio-Hortega P. Del the Microglia. Lancet 1939;233:1023-6.
14. Tremblay ME, Lecours C, Samson L, Sanchez-Zafra V, Sierra A. From the cajal alumni achucarro and Rio-Hortega to the rediscovery of
never-resting microglia. Front Neuroanat 2015;9:45.
15. McGeer PL, Itagaki S, McGeer EG. Expression of the histocompatibility glycoprotein HLA-DR in neurological disease. Acta
Neuropathol 1988;76:550-7.
16. McGeer PL, Itagaki S, Tago H, McGeer EG. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the
histocompatibility glycoprotein HLA-DR. Neurosci Lett 1987;79:195-200.
17. McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and
Alzheimer’s disease brains. Neurology 1988;38:1285-91.
18. Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J
Neuroimmunol 1989;24:173-82.
19. Rogers J, Luber-Narod J, Styren SD, Civin WH. Expression of immune system-associated antigens by cells of the human central nervous
system: relationship to the pathology of Alzheimer’s disease. Neurobiol Aging 1988;9:339-49.
20. Mattiace LA, Davies P, Dickson DW. Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical
factors. Am J Pathol 1990;136:1101-14.
21. Nakagawa T, Ohnishi K, Kosaki Y, Saito Y, Horlad H, et al. Optimum immunohistochemical procedures for analysis of macrophages in
human and mouse formalin fixed paraffin-embedded tissue samples. J Clin Exp Hematop 2017;57:31-6.
22. Beach TG, Adler CH, Sue LI, Serrano G, Shill HA, Walker DG, et al. Arizona Study of Aging and Neurodegenerative Disorders and
Brain and Body Donation Program. Neuropathology 2015;35:354-89.
23. Beach TG, Sue LI, Walker DG, Roher AE, Lue L, et al. The sun health research institute brain donation program: description and
experience, 1987-2007. Cell Tissue Bank 2008;9:229-45.
24. Friedman BA, Srinivasan K, Ayalon G, Meilandt WJ, Lin H, et al. Diverse brain myeloid expression profiles reveal distinct microglial
activation states and aspects of Alzheimer’s disease not evident in mouse models. Cell Rep 2018;22:83247.
25. Bennett ML, Bennett FC, Liddelow SA, Ajami B, Zamanian JL, et al. New tools for studying microglia in the mouse and human CNS.
Proc Natl Acad Sci U S A 2016;113:E1738-46.
26. Zhou Y, Song WM, Andhey PS, Swain A, Levy T, et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and
TREM2-independent cellular responses in Alzheimer’s disease. Nat Med 2020;26:131-42.
27. van der Poel M, Ulas T, Mizee MR, Hsiao CC, Miedema SSM, et al. Transcriptional profiling of human microglia reveals grey-white
matter heterogeneity and multiple sclerosis-associated changes. Nat Commun 2019;10:1139.
28. Zrzavy T, Hametner S, Wimmer I, Butovsky O, Weiner HL, et al. Loss of “homeostatic” microglia and patterns of their activation in
active multiple sclerosis. Brain 2017;140:1900-13.
29. Li Q, Cheng Z, Zhou L, Darmanis S, Neff NF, et al. Developmental heterogeneity of microglia and brain myeloid cells revealed by deep
single-cell RNA sequencing. Neuron 2019;101:207-23.e10.
30. Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, et al. Identification of a unique TGF-beta-dependent molecular and
functional signature in microglia. Nat Neurosci 2014;17:131-43.
31. Hickman SE, Kingery ND, Ohsumi TK, Borowsky ML, Wang L, et al. The microglial sensome revealed by direct RNA sequencing. Nat
Neurosci 2013;16:1896-905.
32. Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, et al. A unique microglia type associated with restricting
development of Alzheimer’s disease. Cell 2017;169:1276-90.e17.
33. Deczkowska A, Keren-Shaul H, Weiner A, Colonna M, Schwartz M, et al. Disease-associated microglia: a universal immune sensor of
neurodegeneration. Cell 2018;173:1073-81.
34. Minett T, Classey J, Matthews FE, Fahrenhold M, Taga M, et al. Microglial immunophenotype in dementia with Alzheimer’s pathology. J
Neuroinflammation 2016;13:135.
35. Akiyama H, McGeer PL. Brain microglia constitutively express beta-2 integrins. J Neuroimmunol 1990;30:81-93.
36. McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, et al. Microglia in degenerative neurological disease. Glia 1993;7:84-92.
37. Strittmatter WJ, Saunders AM, Goedert M, Weisgraber KH, Dong LM, et al. Isoform-specific interactions of apolipoprotein E with
microtubule-associated protein tau: implications for Alzheimer disease. Proc Natl Acad Sci U S A 1994;91:11183-6.
38. Saunders AM, Schmader K, Breitner JC, Benson MD, Brown WT, et al. Apolipoprotein E epsilon 4 allele distributions in late-onset
Alzheimer’s disease and in other amyloid-forming diseases. Lancet (London, England) 1993;342:710-1.
39. Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, et al. Apolipoprotein E associates with beta amyloid peptide of
Alzheimer’s disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J Clin Invest 1994;94:860-9.
40. Yamaguchi H, Ishiguro K, Sugihara S, Nakazato Y, Kawarabayashi T, et al. Presence of apolipoprotein E on extracellular neurofibrillary
tangles and on meningeal blood vessels precedes the Alzheimer beta-amyloid deposition. Acta Neuropathol 1994;88:413-9.
41. Diedrich JF, Minnigan H, Carp RI, Whitaker JN, Race R, et al. Neuropathological changes in scrapie and Alzheimer’s disease are
associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol 1991;65:4759-68.
42. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and
neurofibrillary tangles in Alzheimer’s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991;541:163-6.
43. Uchihara T, Duyckaerts C, He Y, Kobayashi K, Seilhean D, et al. ApoE immunoreactivity and microglial cells in Alzheimer’s disease
brain. Neurosci Lett 1995;195:5-8.
44. McGeer PL, Akiyama H, Itagaki S, McGeer EG. Activation of the classical complement pathway in brain tissue of Alzheimer patients.